Steward Partners Investment Advisory, LLC Bei Gene, Ltd. Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 699 shares of BGNE stock, worth $126,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
699
Previous 704
0.71%
Holding current value
$126,267
Previous $100,000
56.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.91 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.16 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$935 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$899 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$669 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $18.7B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...